SCHEMBL29372199

SCHEMBL29372199

Cc1ccc(C)c(P(=O)(C(=O)c2c(Cl)ccc3ccccc23)C(=O)c2c(Cl)ccc3ccccc23)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
POLB P06746 1/20 0.38
GAA P10253 1/20 0.38
S1PR4 O95977 1/20 0.38
NPC1 O15118 4/20 0.38
RAB9A P51151 4/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TAS1R3 Q7RTX0 3/20 0.37
TAS1R1 Q7RTX1 3/20 0.37
TAS1R2 Q8TE23 3/20 0.37
ABCG2 Q9UNQ0 1/20 0.36
CYP2A6 P11509 3/20 0.36
CYP1A2 P05177 2/20 0.36
CNR2 P34972 1/20 0.35
STK39 Q9UEW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL58468 1.00 MEN1 (0.38) MEN1KMT2APOLBGAAS1PR4
SCHEMBL29374425 0.90 TAS1R3 (0.42) MEN1KMT2APOLBGAANPC1
SCHEMBL57625 0.90 TAS1R3 (0.42) MEN1KMT2APOLBGAANPC1
SCHEMBL5898571 0.83 CNR2 (0.42) MEN1KMT2APOLBGAANPC1
SCHEMBL29365063 0.83 GAA (0.40) KMT2APOLBGAAS1PR4RAB9A
SCHEMBL58444 0.83 GAA (0.40) KMT2APOLBGAAS1PR4RAB9A
SCHEMBL29934137 0.76 CYP2A6 (0.39) MEN1KMT2APOLBGAAS1PR4
SCHEMBL6469382 0.75 S1PR4 (0.43) MEN1KMT2AGAAS1PR4SMN1; SMN2
SCHEMBL28674909 0.74 TAS1R3 (0.45) POLBNPC1RAB9ATAS1R3TAS1R1
SCHEMBL3415394 0.73 ABCG2 (0.37) MEN1KMT2APOLBGAAS1PR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260028440-A1 Curable Composition for Producing Transparent Orthodontic Attachments SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2026-01-29 US disclosed
EP-4629958-A1 SURFACE-TREATED FILLER, DENTAL COMPOSITION CONTAINING SUCH A FILLER, PROCESS OF PRODUCTION AND USE THEREOF Solventum Intellectual Properties Company (US) 2025-10-15 EP disclosed
CN-120091917-A Method for producing laminate, inkjet ink, and image recording method 富士胶片株式会社 2025-06-03 CN disclosed
EP-4558086-A1 CURABLE COMPOSITION FOR PRODUCING TRANSPARENT ORTHODONTIC ATTACHMENTS Solventum Intellectual Properties Company (US) 2025-05-28 EP disclosed
CN-119968271-A Method for producing laminate, inkjet ink, and image recording method 富士胶片株式会社 2025-05-09 CN disclosed
CN-116507309-B Dental pH sensitive microcapsules 舒万诺知识产权公司 2025-03-25 CN disclosed
CN-119584936-A Curable composition for producing transparent orthodontic accessories 舒万诺知识产权公司 2025-03-07 CN disclosed
EP-4514304-A1 DENTAL COMPOSITION CONTAINING A RESORCINOL OR CATECHOL MOIETY CONTAINING COMPONENT AND USE THEREOF Solventum Intellectual Properties Company (US) 2025-03-05 EP disclosed
CN-119161764-A Active energy ray-curable inkjet ink, image recording method, and method for producing molded article 富士胶片株式会社 2024-12-20 CN disclosed
CN-119136772-A Dental composition comprising a component comprising resorcinol or catechol moieties and uses thereof 舒万诺知识产权公司 2024-12-13 CN disclosed
WO-2023012556-A1 COMPOSITION FOR ISOLATING TISSUE 3M INNOVATIVE PROPERTIES COMPANY (US) 2023-02-09 WO disclosed
WO-2023275637-A1 DENTAL CEMENT COMPOSITION, KIT OF PARTS AND USE THEREOF 3M INNOVATIVE PROPERTIES COMPANY (US) 2023-01-05 WO disclosed
CN-115315490-A Ink for ink jet recording and image recording method 富士胶片株式会社 2022-11-08 CN disclosed
WO-2022123395-A1 DENTAL RETRACTION COMPOSITION 3M INNOVATIVE PROPERTIES COMPANY (US) 2022-06-16 WO disclosed
CN-110114376-B Curable composition, method for producing cured product, cured product thereof, and adhesive using same 株式会社ADEKA 2022-06-14 CN disclosed
EP-3980175-A1 MICROCAPSULE WITH A POROUS OR HOLLOW CORE AND A SHELL CONTAINING A COMPONENT RELEASING GAS UPON CONTACT WITH AN ACID 3M Innovative Properties Company (US) 2022-04-13 EP disclosed
WO-2022070517-A1 INKJET INK AND IMAGE RECORDING METHOD 富士フイルム株式会社 2022-04-07 WO disclosed
WO-2022054387-A1 INKJET RECORDING INK AND INKJET RECORDING METHOD 富士フイルム株式会社 2022-03-17 WO disclosed
CN-110325601-B Liquid composition for inkjet and inkjet recording method 富士胶片株式会社 2022-03-15 CN disclosed
CN-106535861-B Two-component self-adhesive dental composition, method of making and using the same 3M创新有限公司 2022-02-08 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260028440-A1 Curable Composition for Producing Transparent Orthodontic Attachments SMCHD1, SMC2, SMC1A MEN1 1235/4885KMT2A 118/4885POLB 582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.